Target intelligence / Profile preview

RNA, U7 small nuclear 21 pseudogene (RNU7-21P)

Target
RNU7-21P
Molecular classification
Other (pseudogene, small nuclear RNA pseudogene)
01

Overview

The RNA, U7 small nuclear 21 pseudogene (RNU7-21P) is a noncoding RNA considered a pseudogene related to the U7 small nuclear RNA gene family. Pseudogenes are typically nonfunctional remnants of genes that have lost their protein-coding potential due to mutations. U7 small nuclear RNA itself is essential for histone pre-mRNA processing as part of the U7 small nuclear ribonucleoprotein (snRNP) complex, but RNU7-21P does not encode a functional product. There is no evidence that RNU7-21P is expressed, involved in biological pathways, or is implicated in disease processes, nor is it considered a therapeutic target. Key details: - RNU7-21P is a **pseudogene**, not a functional gene or protein. - It is related to the **U7 small nuclear RNA** family, which is involved in histone pre-mRNA processing. However, only functional homologs like RNU7-1 are biologically relevant in this process[1][2][4][5]. - There are **no known drugs, disease associations, or targeted therapies** relevant to RNU7-21P. - It is **not a validated therapeutic target**, nor are there biological functions or mechanisms of action ascribed to it. Note: The functional gene with biological and disease relevance is **RNU7-1** (RNA, U7 small nuclear 1), which is involved in histone mRNA processing and can be implicated in rare disorders such as Aicardi-Goutières syndrome when mutated[1][2][5]. In contrast, RNU7-21P is a pseudogene and does not share these associations.

Other names
U7.21U7.21 pseudogeneRNA, small nuclear U7.21 pseudogeneRNU7-21P

Beyond the preview

Go deeper on RNA, U7 small nuclear 21 pseudogene (RNU7-21P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U7 small nuclear 21 pseudogene (RNU7-21P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call